NASDAQ
Collegium Pharmaceutical, Inc. (COLL) has a price/fcf ratio of 4.48x as of Monday, May 25, 2026. This represents a 15.28% decrease compared to its 12-month average of 5.29x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.